📢 New funding opportunity
The D2R Strategic Initiative on Cancer Vaccines will support multidisciplinary teams advancing neoantigen-based cancer vaccines toward clinical implementation, including first-in-human studies.
📅 LOI deadline: Sept. 1, 2026 (9 a.m. ET)
🔗 www.mcgill.ca/dna-to-rna/f...
